These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35670632)

  • 1. Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Moriconi C; Dzieciatkowska M; Roy M; D'Alessandro A; Roingeard P; Lee JY; Gibb DR; Tredicine M; McGill MA; Qiu A; La Carpia F; Francis RO; Hod EA; Thomas T; Picard M; Akpan IJ; Luckey CJ; Zimring JC; Spitalnik SL; Hudson KE
    Br J Haematol; 2022 Aug; 198(3):574-586. PubMed ID: 35670632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.
    Jagadeeswaran R; Vazquez BA; Thiruppathi M; Ganesh BB; Ibanez V; Cui S; Engel JD; Diamond AM; Molokie RE; DeSimone J; Lavelle D; Rivers A
    Exp Hematol; 2017 Jun; 50():46-52. PubMed ID: 28238805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress.
    Esperti S; Nader E; Stier A; Boisson C; Carin R; Marano M; Robert M; Martin M; Horand F; Cibiel A; Renoux C; Van Bruggen R; Blans C; Dargaud Y; Joly P; Gauthier A; Poutrel S; Romana M; Roussel D; Connes P
    Haematologica; 2023 Nov; 108(11):3086-3094. PubMed ID: 37259576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease.
    Chang DY; Wankier Z; Arthur CM; Stowell SR
    Presse Med; 2023 Dec; 52(4):104211. PubMed ID: 37981194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
    Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting red blood cell units to perform RBCX in patients with sickle cell disease.
    Raba M
    Transfus Apher Sci; 2019 Apr; 58(2):142-146. PubMed ID: 30910616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of alloimmunization in sickle cell disease.
    Hudson KE; Fasano RM; Karafin MS; Hendrickson JE; Francis RO
    Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic study of retention and elimination of abnormal red blood cells by human spleen with implications for sickle cell disease.
    Qiang Y; Sissoko A; Liu ZL; Dong T; Zheng F; Kong F; Higgins JM; Karniadakis GE; Buffet PA; Suresh S; Dao M
    Proc Natl Acad Sci U S A; 2023 Feb; 120(6):e2217607120. PubMed ID: 36730189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More efficient exchange of sickle red blood cells can be achieved by exchanging the densest red blood cells: An ex vivo proof of concept study.
    Thibodeaux SR; Tanhehco YC; Irwin L; Jamensky L; Schell K; O'Doherty U
    Transfus Apher Sci; 2019 Feb; 58(1):100-106. PubMed ID: 30616959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Unique Magnetic Signature of Sickle Red Blood Cells: A Comparison Between the Red Blood Cells of Transfused and Non-Transfused Sickle Cell Disease Patients and Healthy Donors.
    Weigand M; Gomez-Pastora J; Strayer J; Wu X; Choe H; Lu S; Plencner E; Landes K; Palmer A; Zborowski M; Desai P; Chalmers J
    IEEE Trans Biomed Eng; 2022 Dec; 69(12):3582-3590. PubMed ID: 35544484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined computational and experimental investigation of the filtration function of splenic macrophages in sickle cell disease.
    Li G; Qiang Y; Li H; Li X; Buffet PA; Dao M; Karniadakis GE
    PLoS Comput Biol; 2023 Dec; 19(12):e1011223. PubMed ID: 38091361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness.
    Connes P
    Clin Hemorheol Microcirc; 2024; 86(1-2):9-27. PubMed ID: 38073384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.
    Simmonds MJ; Suriany S; Ponce D; Detterich JA
    Transfusion; 2018 Dec; 58(12):2788-2796. PubMed ID: 30325033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.